DrugPatentWatch Database Preview
Teva Branded Pharm Company Profile
» See Plans and Pricing
What is the competitive landscape for TEVA BRANDED PHARM, and when can generic versions of TEVA BRANDED PHARM drugs launch?
TEVA BRANDED PHARM has thirty-one approved drugs.
There are fifty-two US patents protecting TEVA BRANDED PHARM drugs.
There are six hundred and fifty patent family members on TEVA BRANDED PHARM drugs in forty-one countries and twenty-four supplementary protection certificates in thirteen countries.
Summary for Teva Branded Pharm
International Patents: | 650 |
US Patents: | 52 |
Tradenames: | 31 |
Ingredients: | 17 |
NDAs: | 31 |
Patent Litigation for Teva Branded Pharm: | See patent lawsuits for Teva Branded Pharm |
Drugs and US Patents for Teva Branded Pharm
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Teva Branded Pharm | MIRCETTE | desogestrel; ethinyl estradiol | TABLET;ORAL-28 | 020713-001 | Apr 22, 1998 | DISCN | Yes | No | Start Trial | Start Trial | |||||
Teva Branded Pharm | PROAIR RESPICLICK | albuterol sulfate | POWDER, METERED;INHALATION | 205636-001 | Mar 31, 2015 | RX | Yes | Yes | 9,731,087 | Start Trial | Y | Start Trial | |||
Teva Branded Pharm | PROAIR RESPICLICK | albuterol sulfate | POWDER, METERED;INHALATION | 205636-001 | Mar 31, 2015 | RX | Yes | Yes | 6,718,972 | Start Trial | Y | Start Trial | |||
Teva Branded Pharm | LOESTRIN 24 FE | ethinyl estradiol; norethindrone acetate | TABLET;ORAL | 021871-001 | Feb 17, 2006 | AB | RX | Yes | No | Start Trial | Start Trial | ||||
Teva Branded Pharm | PROAIR DIGIHALER | albuterol sulfate | POWDER, METERED;INHALATION | 205636-002 | Dec 21, 2018 | RX | Yes | No | 10,022,510 | Start Trial | Y | Start Trial | |||
Teva Branded Pharm | PROAIR RESPICLICK | albuterol sulfate | POWDER, METERED;INHALATION | 205636-001 | Mar 31, 2015 | RX | Yes | Yes | 10,561,808 | Start Trial | Y | Start Trial | |||
Teva Branded Pharm | LOESTRIN FE 1/20 | ethinyl estradiol; norethindrone acetate | TABLET;ORAL-28 | 017354-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | Start Trial | Start Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Teva Branded Pharm
Paragraph IV (Patent) Challenges for TEVA BRANDED PHARM drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Tablets | 0.1 mg/0.02 mg and 0.01 mg | ➤ Subscribe | 2009-11-16 |
➤ Subscribe | Tablets | 0.15 mg/0.03 mg | ➤ Subscribe | 2004-03-29 |
➤ Subscribe | Tablets | 1 mg/0.02 mg and 75 mg | ➤ Subscribe | 2006-04-17 |
➤ Subscribe | Tablets | 0.15 mg/0.02 mg, 0.15 mg/0.025 mg, 0.15 mg/0.03 mg and 0.01 mg | ➤ Subscribe | 2013-07-10 |
➤ Subscribe | Tablets | 0.15 mg/0.03 mg/0.01 mg | ➤ Subscribe | 2008-01-22 |
International Patents for Teva Branded Pharm Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Japan | 2015231584 | Start Trial |
Russian Federation | 2351339 | Start Trial |
World Intellectual Property Organization (WIPO) | 0197889 | Start Trial |
Eurasian Patent Organization | 201690641 | Start Trial |
Argentina | 028747 | Start Trial |
Austria | 150296 | Start Trial |
Portugal | 3061760 | Start Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Teva Branded Pharm Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1453521 | 15C0050 | France | Start Trial | PRODUCT NAME: ETHINYLESTRADIOL ET MELANGE DE LEVONORGESTREL ET ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: NL 42237 20150320; FIRST REGISTRATION: SK - 17/0017/15-S 20150129 |
1453521 | C20160011 00192 | Estonia | Start Trial | PRODUCT NAME: LEVONORGESTREEL JA ETUENUEUELOESTRADIOOL;REG NO/DATE: EE 894715 11.11.2015 |
1389098 | C300609 | Netherlands | Start Trial | PRODUCT NAME: LOXAPINE; REGISTRATION NO/DATE: EU/1/13/823/001-002 20130220 |
1214076 | C01214076/01 | Switzerland | Start Trial | PRODUCT NAME: DROSPIRENONE + ETHINYLESTRADIOL; REGISTRATION NUMBER/DATE: SWISSMEDIC 57946 13.06.2008 |
1389098 | 300609 | Netherlands | Start Trial | PRODUCT NAME: LOXAPINE; REGISTRATION NO/DATE: EU/1/13/823/001-002 20130220 |
1380301 | CA 2009 00017 | Denmark | Start Trial | PRODUCT NAME: ETHINYLESTRADIOL (SOM BETADEXCLATHRAT) OG DROSPIRENON; NAT. REG. NO/DATE: 42417 (DK) 20080619; FIRST REG. NO/DATE: NL 33842 20070629 |
0771217 | 07C0001 | France | Start Trial | PRODUCT NAME: ETHINYLESTRADIOL BETADEX CLATHRATE; NAT. REGISTRATION NO/DATE: NL 32343 20060710; FIRST REGISTRATION: NL - RVG 31781 20050804 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.